Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pirfenidone for Uterine Leiomyoma
NCT00332033Phase 2Completed
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pirfenidone in uterine leiomyoma, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Started May 2006; status: completed.
02
Drugs
pirfenidone
03
Conditions
uterine leiomyoma
Beyond the preview
Go deeper on NCT00332033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00332033.